lung
High tumor mutational burden (TMB) predicts not only response to immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) but also immune-related toxicity. In this single-center cohort of 1,215 patients treated with ICI...
…In this panel discussion, surgeons Leanne Ashrafian and Andrea Bille, both consultant thoracic surgeons in the Department of Thoracic Surgery at Guy’s St Thomas’ NHS Foundation Trust, join Ammara Watkins,...
…This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Timur Kyashif, a cardiac resident at Jena University Hospital in Jena, Germany, about the German Society for Thoracic, Cardiac,...
In this noteworthy interview, CTSNet Editor-in-Chief Joel Dunning speaks with Jeffrey Velotta, Assistant Clinical Professor of Surgery at the University of California, San Francisco School of Medicine in San Francisco,...
…This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Jeffrey Velotta, Assistant Clinical Professor of Surgery at the University of California, San Francisco School of Medicine in San...
